Tag: FDA

Translational and Early Phase Strategies for Treatment Development: Report of ISCTM Autumn 2013 Symposium
by Jared W. Young, PhD; William Z. Potter, MD, PhD; Steve Riley, PharmD, PhD; Geert J. Groeneveld, MD, PhD; Bruce J. Kinon, MD; Mike F. Egan, MD; and Douglas E. Feltner, MD Dr. Young is with the Department of Psychiatry, University of California San Diego, La Jolla, California, and Research Service, VA San Diego Healthcare […]

Decreased Use of Antidepressants in Youth After US Food and Drug Administration Black Box Warning
by Tanvir Singh, MD; Ashwin Prakash, MD; Theodore Rais, MD; and Neeta Kumari, MD, MPH Dr. Singh is Assistant Professor, Department of Child and Adolescent Psychiatry, University of Toledo Medical Center, Toledo, Ohio; Dr. Prakash is from the Department of Child and Adolescent Psychiatry, University of Toledo Medical Center, Toledo, Ohio; Dr. Rais is Associate […]